GFG
CVS icon

Greystone Financial Group’s CVS Health CVS Stock Holding History

Greystone Financial Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,127
Closed -$1.19M – 113
2023
Q4 		$1.19M Sell
15,127
-558
-4% -$39.7K 0.28% 55
2023
Q3 		$1.1M Sell
15,685
-908
-5% -$64.3K 0.27% 55
2023
Q2 		$1.15M Sell
16,593
-1,239
-7% -$88.2K 0.27% 57
2023
Q1 		$1.33M Buy
17,832
+4,582
+35% +$384K 0.33% 48
2022
Q4 		$1.23M Sell
13,250
-78
-0.6% -$7.53K 0.36% 42
2022
Q3 		$1.27M Sell
13,328
-3,243
-20% -$321K 0.43% 43
2022
Q2 		$1.53M Sell
16,571
-48
-0.3% -$4.68K 0.48% 41
2022
Q1 		$1.68M Sell
16,619
-850
-5% -$89.3K 0.43% 50
2021
Q4 		$1.8M Buy
17,469
+3,847
+28% +$355K 0.43% 49
2021
Q3 		$1.16M Sell
13,622
-2,977
-18% -$249K 0.34% 52
2021
Q2 		$1.39M Buy
16,599
+559
+3% +$45.8K 0.34% 57
2021
Q1 		$1.35M Buy
16,040
+3,530
+28% +$257K 0.34% 53
2020
Q4 		$913K Buy
+12,510
New +$814K 0.25% 62

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Greystone Financial Group's CVS Position: Q1 2024 in Review

Greystone Financial Group sold out of CVS Health (CVS) in Q1 2024, closing a stake of 15,127 shares — an estimated $1.19M sold.

Greystone Financial Group first reported a position in CVS in Q4 2020 and held it in 13 quarters. The position peaked at $1.8M in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Greystone Financial Group reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Greystone Financial Group sold 15,127 CVS Health shares in Q1 2024, an estimated $1.19M.
  • Greystone Financial Group first reported a position in CVS Health in Q4 2020 and held it in 13 quarters.
  • Greystone Financial Group's CVS Health position peaked at $1.8M in Q4 2021.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Greystone Financial Group's 13F filing for Q1 2024, filed 22 Apr 2024.